Please login to the form below

Not currently logged in
Email:
Password:

Research and Development

This page shows the latest Research and Development news and features for those working in and with pharma, biotech and healthcare.

BenevolentAI claims AI first with new Cambridge facility

BenevolentAI claims AI first with new Cambridge facility

BenevolentAI claims AI first with new Cambridge facility. Says its new drug discovery and development base will cover the entire research process. ... The UK’s BenevolentAI has acquired a new drug discovery and development base in Cambridge, UK that it

Latest news

  • Microsoft brings its AI network to cardiology Microsoft brings its AI network to cardiology

    That launch, which will use Microsoft’s Azure cloud computing platform, will see it partner with the Tennessee-based St Jude Children’s Research Hospital. ... research and product development to help healthcare providers, biotech companies and

  • Roche to buy cancer data firm Flatiron for $1.9bn Roche to buy cancer data firm Flatiron for $1.9bn

    Roche Pharma chief executive Daniel O’Day “is a key ingredient to accelerate the development of, and access to, new cancer treatments”. ... but for oncology research and development efforts across the entire industry”.

  • Fujitsu begins two-year medical AI research project Fujitsu begins two-year medical AI research project

    The partners are focused on AI ’s possibilities in accelerating the research and development of next-generation medicine, such as new approaches to diagnostics and drug discovery. ... Meanwhile, last year saw an uptick in life sciences interest in

  • Pharma must do more on antibiotic resistance, Davos meeting hears Pharma must do more on antibiotic resistance, Davos meeting hears

    The benchmark study reveals that GlaxoSmithKline (GSK) and Johnson &Johnson (J&J) are leading the charge against AMR among 30 companies active in new antimicrobial research. ... But the scale of the task ahead remains acute. Specifically… we need to

  • Amgen and Allergan win first EU approval for Avastin biosimilar Amgen and Allergan win first EU approval for Avastin biosimilar

    Sean Harper, executive vice president of research and development at Amgen, said: “The EC’s approval of Mvasi marks a significant milestone for both Amgen and the oncology community, providing a ... David Nicholson, chief research and development

More from news
Approximately 10 fully matching, plus 664 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 78 partially matching documents found.

Latest appointments

  • Metrion Biosciences adds to its board Metrion Biosciences adds to its board

    Metrion Biosciences, the specialist ion channel contract research and drug discovery group, has appointed Dr Barry Kenny and Dr Andrew Southan to its board of directors, a move that will see ... He has over 25 years’experience in ion channel research

  • Editas Medicine adds to its board of directors Editas Medicine adds to its board of directors

    Dr Hopfield has more than two decades worth of experience in the medical and healthcare fields and she has held management positions at Merck Sharp &Dohme ( MSD) in clinical development, outcomes ... research and marketing.

  • Robert Freisen joins Ablynx Robert Freisen joins Ablynx

    Ablynx, recently acquired by Sanofi, has appointed Robert Freisen to the role of chief scientific officer, who will head the biopharma’s scientific research and technology activities. ... Freisen has more than 20 years’experience in the

  • Professor Carole Longson moves from NICE to the ABPI Professor Carole Longson moves from NICE to the ABPI

    She will also shape and develop UK pharmaceutical science policy and will ensure that the UK “remains at the forefront of innovation in medicines research, development and manufacturing”. ... Her scientific research and academic experience, along

  • Glythera strengthens its scientific advisory board and appoints CSO Glythera strengthens its scientific advisory board and appoints CSO

    Dr Lutz was previously vice president of translation research and development at ImmunoGen, where he was responsible for all early-stage ADC development programmes. ... Additionally, Dr Jon Roffey joins Glythera ’s scientific advisory board (SAB) from

More from appointments
Approximately 0 fully matching, plus 155 partially matching documents found.

Latest from PMHub

  • Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies

    Currently, biotech companies and big pharma are pouring money into this sector, in the hope of advancing research and development and discovering the next big breakthrough. ... The half-light of the truth. Prior to landing the job of CEO in 2014, Olav

  • Investigator meetings deconstructed

    Investigator meetings deconstructed. With our expertise in clinical meetings and our understanding of their significance to the drug development process, we have put together some of our expert insights to help ... As  our own research shows,

  • Life at the end of the Brexit tunnel

    A Vaccines Development and Manufacturing Centre to develop vaccines for clinical trials and emergency epidemics. ... R&D to support innovation at the manufacturing centres . Government has increased investment in research and development over the next 4

  • Forever Angels achievements and development plan for 2016

    Forever Angels achievements and development plan for 2016. Research Partnership is proud to support Forever Angels in their mission of caring for and improving the lives of orphans and abandoned infants ... overcome and future plans so they can continue

  • Research and development

    Research and development. This Research and development section features Research and development companies, inc drug development;. ... VPA’ s aim is to solve our clients’ product research, development and commercialisation challenges so they can

More from PMHub
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics